Business Wire

Revance Reports Positive Results from ASPEN-1 Phase 3 Trial of DaxibotulinumtoxinA for Injection in Cervical Dystonia

NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced positive topline results ...
Business Wire

Revance to Showcase Phase 3 Results Evaluating DaxibotulinumtoxinA for Injection for the Treatment of Cervical Dystonia at the American Academy of Neurology Annual 2021 Virtual ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the company will present an ...
Medscape

Cervical Transforaminal Epidural Steroid Injection for Cervical Radiculopathy and Its Association With CNS Injury

Dr. Dawley and colleagues sought to affirm the possibility that intra-arterial injection of commonly used corticosteroids could lead to central nervous system injury during a transforaminal epidural ...
Nasdaq

Revance Announces U.S. FDA Acceptance of Supplemental Biologics License Application (sBLA) for DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical ...

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License ...

HPV vaccination up to 45: A key step in preventing cervical cancer

Cervical cancer myths hinder prevention, emphasizing the need for education and HPV vaccination. The HPV vaccine, effective ...